본문 바로가기

Predictions of Oncotype DX® High-Risk Classification Using Magnetic Resonance Imaging-Based Intratumoral Heterogeneity

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q2Scopus Q3
저널
BIOENGINEERING-BASEL13(6) · 2026
피인용
Web of Science 0Scopus 0
FWCI (Scopus)
0
JCR IF
JCR 2024 3.7
ISSN
2306-5354

저자

  1. Park, Sung Joon제1저자Kyungpook Natl Univ, Sch Comp Sci & Engn, Daegu 41566, South Korea
  2. Kim, Won HwaBeamWorks Inc, Daegu 41566, South Korea
  3. Kim, JaeilKyungpook Natl Univ, Sch Comp Sci & Engn, Daegu 41566, South Korea
  4. 강태우Pusan Natl Univ, Sch Med, Dept Surg, Busan 49241, South Korea
  5. Park, Ji-YoungKyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Pathol, Daegu 41404, South Korea
  6. Kang, ByeongjuKyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Surg, Daegu 41404, South Korea
  7. Moon, Joon SukKyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Surg, Daegu 41404, South Korea
  8. Park, Ho YongKyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Surg, Daegu 41404, South Korea
  9. Kim, Hye JungKyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Radiol, Daegu 41404, South Korea
  10. Lee, Jeeyeon교신저자Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Surg, Daegu 41404, South Korea

초록

The Oncotype DX® 21-gene recurrence score (RS) guides adjuvant chemotherapy decisions in estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+/HER2−) breast cancer, yet requires invasive tissue sampling and involves substantial costs. This study evaluated intratumoral tumor ecological diversity (iTED), a habitat imaging approach, as a non-invasive complement for predicting Oncotype DX® high-risk classification (RS > 25). This retrospective multi-center study included 312 patients with ER+/HER2− invasive breast cancer who underwent Oncotype DX® testing (development: n = 168; external validation: n = 144). The iTED framework employed superpixel-based habitat determination using Gaussian mixture models on pretreatment dynamic contrast-enhanced MRI. Four predictive models were compared: clinical, conventional whole-tumor radiomics (C-radiomics), iTED, and combined (Clinical + iTED). The iTED model achieved higher discriminative performance compared with C-radiomics in both development (area under the curve [AUC]: 0.868 ± 0.068 vs. 0.730 ± 0.112) and external validation (AUC: 0.811 vs. 0.587) sets. The combined model further improved performance (development AUC: 0.908 ± 0.043; external AUC: 0.889). Habitat imaging-based iTED features achieved numerically higher performance than conventional radiomics in predicting Oncotype DX® high-risk classification. These findings suggest the potential of iTED as a non-invasive imaging biomarker to support molecular testing in clinical decision-making.

키워드

breast cancerdynamic contrast-enhanced magnetic resonance imaginghabitat imagingintratumoral heterogeneityiTEDOncotype DX®radiomics

식별자

Scopus EID
2-s2.0-105042901996
WoS UID
001804284300001